Mereo BioPharma Group PLC (LSE:MPH) - Share price


Stock Report

Mereo BioPharma Group PLC MPH

Last Price
GBX41.00

Day Change
-1.50|-3.53%

As of 19/07/2019
15:55:53 BST | GBX
Minimum 15 Minutes Delay.

Last Close42.50p
Day Range40.00 - 42.00
Mkt Cap40.16Mil
52-Wk Range40.00 - 320.00
Yield %-
ISINGB00BZ4G2K23
Volume79,126
P/E-0.91
P/S-
P/CF-0.01

Share Price

Total Returns 19/07/2019

 Chg (%)  
More ...
Mereo BioPharma Group PLC-32.79 
FTSE 100 TR GBP1.56
 
Financials
201620172018
More ...
Income Statement
Turnover---
Operating Profit-36.18-45.30-35.21
Net Profit-28.39-38.80-32.03
Reported EPS-63.00-56.00-45.00
Balance Sheet
Current Assets60.7863.1834.50
Non Current Assets25.9933.1632.78
Total Assets86.7796.3467.28
Current Liabilities3.219.6216.18
Total Liabilities---
Total Equity79.2662.4832.77
Cash Flow
Operating Cash Flow-30.61-37.48-31.29
Net Change in Cash39.07-2.15-24.96
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
18/07/2019PurchaseDr. Denise Vera Scots-Knight0.5210,0005,180.00
18/07/2019PurchaseDr. Denise Vera Scots-Knight45.008,0003,600.00
17/07/2019PurchaseDr. Denise Vera Scots-Knight0.5210,0005,180.00
17/07/2019PurchaseDr. Denise Vera Scots-Knight45.002,000900.00

Company Profile

Mereo BioPharma Group PLC is a multi-asset biopharmaceutical company. It is focused on the acquisition, development and commercialization of innovative therapeutics to improve outcomes for patients with rare and specialty diseases.

Sector

Biotechnology

Index

Next Event 08/08/2019

Half-Yearly Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-67.90
Op Mrgn0.00
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
DirectorMr. Michael Stephen Wyzga
DirectorDr. Deepika Rachel Pakianathan
DirectorMr. Anders Olof Adolf Ekblom
DirectorMr. Paul Frederick Blackburn
DirectorDr. Peter James Jonathan Bains
DirectorMr. Kunal Ashok Kashyap
Principal Accounting Officer, Chief Financial Officer and DirectorMr. Richard Crispin Morgan Jones
Chief Executive Officer and DirectorDr. Denise Vera Scots-Knight
General Counsel and SecretaryMr. Charles Sermon
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.